An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial

OBJECTIVES: We will investigate the effectiveness of high dose Interferon Beta 1a, compared to low dose Interferon Beta 1a (the base therapeutic regimen) in COVID-19 Confirmed Cases (Either RT-PCR or CT Scan Confirmed) with moderate to severe disease TRIAL DESIGN: This is a single center, open label...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Trials
Glavni autori: Alavi Darazam, Ilad, Hatami, Firouze, Rabiei, Mohammad Mahdi, Pourhoseingholi, Mohamad Amin, Moradi, Omid, Shokouhi, Shervin, Hajesmaeili, Mohammad Reza, Shabani, Minoosh, Irvani, Seyed Sina Naghibi
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Letter
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7586665/
https://ncbi.nlm.nih.gov/pubmed/33106183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04812-2
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items